Alnylam Pharmaceuticals (ALNY) Revenue (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.39% |
| Dec 31, 2025 | -12.17% |
| Sep 30, 2025 | 61.44% |
| Jun 30, 2025 | 2,478.96% |
| Mar 31, 2025 | -94.94% |
| Dec 31, 2024 | 18.42% |
| Sep 30, 2024 | -24.08% |
| Jun 30, 2024 | 33.48% |
| Mar 31, 2024 | 12.42% |
| Dec 31, 2023 | -41.41% |
| Sep 30, 2023 | 135.46% |
| Jun 30, 2023 | -0.17% |
| Mar 31, 2023 | -4.70% |
| Dec 31, 2022 | 26.76% |
| Sep 30, 2022 | 17.56% |
| Jun 30, 2022 | 5.42% |
| Mar 31, 2022 | -17.51% |
| Dec 31, 2021 | 37.79% |
| Sep 30, 2021 | -14.93% |
| Jun 30, 2021 | 24.21% |
| Mar 31, 2021 | 8.56% |
| Dec 31, 2020 | 29.96% |
| Sep 30, 2020 | 21.06% |
| Jun 30, 2020 | 4.51% |
| Mar 31, 2020 | 38.78% |
| Dec 31, 2019 | 2.31% |
| Sep 30, 2019 | 56.69% |
| Jun 30, 2019 | 34.30% |
| Mar 31, 2019 | 58.29% |
| Dec 31, 2018 | 916.58% |
| Sep 30, 2018 | -93.08% |
| Jun 30, 2018 | 36.57% |
| Mar 31, 2018 | -42.26% |
| Dec 31, 2017 | 121.83% |
| Sep 30, 2017 | 7.31% |
| Jun 30, 2017 | -15.97% |
| Mar 31, 2017 | 8.63% |
| Dec 31, 2016 | 27.86% |
| Sep 30, 2016 | 56.75% |
| Jun 30, 2016 | 18.57% |
| Mar 31, 2016 | -2.73% |
| Dec 31, 2015 | 19.40% |
| Sep 30, 2015 | -27.18% |
| Jun 30, 2015 | -53.15% |
| Mar 31, 2015 | -22.82% |
| Dec 31, 2014 | 118.91% |
| Sep 30, 2014 | 50.40% |
| Jun 30, 2014 | -11.84% |
| Mar 31, 2014 | -23.71% |
| Dec 31, 2013 | 20.64% |
| Sep 30, 2013 | 3.50% |
| Jun 30, 2013 | -53.40% |
| Mar 31, 2013 | 119.45% |
| Dec 31, 2012 | -49.31% |
| Sep 30, 2012 | -19.75% |
| Jun 30, 2012 | 1.44% |
| Mar 31, 2012 | 0.65% |
| Dec 31, 2011 | -1.62% |
| Sep 30, 2011 | 0.86% |
| Jun 30, 2011 | -1.35% |
| Mar 31, 2011 | -1.39% |
| Dec 31, 2010 | -23.41% |
| Sep 30, 2010 | 3.95% |
| Jun 30, 2010 | 8.36% |
| Mar 31, 2010 | -7.74% |
| Dec 31, 2009 | 9.80% |
| Sep 30, 2009 | -1.43% |